Latest glioblastoma multiforme Stories
Phase 3 Registration Trial for ICT-107 to Initiate in Second Half of 2015; Financial Results Conference Call to be Held on May 12, 2015 LOS ANGELES, May 11, 2015 /PRNewswire/ -- ImmunoCellular
- DIPG cells respond to TRXE-009 in vitro SYDNEY and SAN DIEGO, May 8, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Limited (ASX:NRT; NASDAQ:NVGN), in conjunction
VANCOUVER, British Columbia and MENLO PARK, Calif., May 7, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc.
Photodynamic therapy with PHOTOFRIN® being studied in range of cancers OAKVILLE, ON, May 7, 2015 /PRNewswire/ - Concordia Healthcare Corp.
Company invites individual and institutional investors as well as advisors to attend real-time VirtualInvestorConferences.com BETHESDA, Md., May 6, 2015 /PRNewswire/ --
Combination Clinical Trial Data Showing Impressive Activity in Bone Cancer and Other Sarcomas LOS ANGELES, May 4, 2015 /PRNewswire/ -- CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical
Following Meeting with FDA, Company Advances Towards Pivotal Phase 2/3 Trial in Patients with Recurrent High Grade Glioma WASHINGTON, May 4, 2015 /PRNewswire/ --
LOS ANGELES, May 1, 2015 /PRNewswire/ -- CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months
SAN DIEGO, April 30, 2015 /PRNewswire/ -- Tocagen Inc., a clinical-stage immuno-oncology company, today announced updated
-VAL-083 Clinical Presentation on Monday, June 1, 2015, from 1:15-4:45 p.m.
- A young chicken: also used as a pet name for children.